3M's Q1 2016 earnings were in line with expectations, showcasing solid operational performance with margin improvements and increased cash flow.  Management's commentary focused on the execution of their 5-year plan, highlighting investments in R&D and business transformation initiatives.  While there was a slight organic sales decline, the company's focus on Health Care and Consumer businesses, along with strategic acquisitions, suggests continued growth potential over the next few weeks.
[1]
